Diabetes, Vol 36, Issue 5 566-570, Copyright © 1987 by American Diabetes Association

ARTICLES

Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels

G Paolisso, S Sgambato, N Passariello, A Scheen, F D'Onofrio and PJ Lefebvre

The aim of this study was to investigate the role of plasma glucagon levels on the blood glucose response to intravenous insulin administered continuously or in a pulsatile manner. Six type I diabetic patients proven to have no residual insulin secretion were investigated. Endogenous glucagon secretion was inhibited by a continuous intravenous infusion of somatostatin (100 micrograms/h) and replaced by exogenous infusions of the hormone at three different rates (7.5, 4.5, and 2.5 micrograms/h), resulting in three different plasma glucagon steady-state levels (i.e., approximately equal to 200, approximately equal to 130, and approximately equal to 75 pg/ml, respectively). Each subject, in random order and on different days, was infused intravenously with regular human insulin either continuously (0.17 mU X kg-1 X min-1) or with the same amount of insulin infused in a pulsatile manner (0.85 mU X kg-1 X min-1 during 2 min followed by 8 min during which no insulin was infused). At plasma glucagon levels approximately equal to 200 pg/ml, blood glucose rose from approximately 10 to approximately 13 mM without any difference between the two modalities of insulin infusion. For plasma glucagon levels approximately equal to 130 pg/ml, plasma glucose remained steady throughout the experiments, but during the last 40 min, plasma glucose levels were significantly lower when insulin was administered intermittently. This greater blood glucose-lowering effect of pulsatile insulin occurred earlier and was more pronounced for plasma glucagon levels averaging 75 pg/ml. We conclude that the greater hypoglycemic effect of insulin administered intravenously in a pulsatile manner in type I diabetics critically depends on plasma glucagon circulating levels.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A.-M. T. Richard, D.-L. Webb, J. M. Goodman, V. Schultz, J. N. Flanagan, L. Getty-Kaushik, J. T. Deeney, G. C. Yaney, G. A. Dunaway, P.-O. Berggren, et al. Tissue-dependent loss of phosphofructokinase-M in mice with interrupted activity of the distal promoter: impairment in insulin secretion Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E794 - E801. [Abstract] [Full Text] [PDF]

				J. M. Grubert, M. Lautz, D. B. Lacy, M. C. Moore, B. Farmer, A. Penaloza, A. D. Cherrington, and O. P. McGuinness Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E232 - E240. [Abstract] [Full Text] [PDF]

				L. Juntti-Berggren, D.-L. Webb, P. O.G. Arkhammar, V. Schultz, E. K. H. Schweda, K. Tornheim, and P.-O. Berggren Dihydroxyacetone-induced Oscillations in Cytoplasmic Free Ca2+ and the ATP/ADP Ratio in Pancreatic {beta}-Cells at Substimulatory Glucose J. Biol. Chem., October 17, 2003; 278(42): 40710 - 40716. [Abstract] [Full Text] [PDF]

				J.-M. Lin, M. E. Fabregat, R. Gomis, and P. Bergsten Pulsatile Insulin Release From Islets Isolated From Three Subjects With Type 2 Diabetes Diabetes, April 1, 2002; 51(4): 988 - 993. [Abstract] [Full Text] [PDF]

				P. Bergsten, J. Westerlund, P. Liss, and P.-O. Carlsson Primary In Vivo Oscillations of Metabolism in the Pancreas Diabetes, March 1, 2002; 51(3): 699 - 703. [Abstract] [Full Text] [PDF]

				N. Porksen, T. Grofte, J. Greisen, A. Mengel, C. Juhl, J. D. Veldhuis, O. Schmitz, M. Rossle, and H. Vilstrup Human insulin release processes measured by intraportal sampling Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E695 - E702. [Abstract] [Full Text] [PDF]

				P. Gilon, M. A. Ravier, J.-C. Jonas, and J.-C. Henquin Control Mechanisms of the Oscillations of Insulin Secretion In Vitro and In Vivo Diabetes, February 1, 2002; 51(90001): S144 - 151. [Abstract] [Full Text] [PDF]

				P. Bergsten Role of Oscillations in Membrane Potential, Cytoplasmic Ca2+, and Metabolism for Plasma Insulin Oscillations Diabetes, February 1, 2002; 51(90001): S171 - 176. [Abstract] [Full Text] [PDF]

				N. Porksen, M. Hollingdal, C. Juhl, P. Butler, J. D. Veldhuis, and O. Schmitz Pulsatile Insulin Secretion: Detection, Regulation, and Role in Diabetes Diabetes, February 1, 2002; 51(90001): S245 - 254. [Abstract] [Full Text] [PDF]